99mTc-TRODAT-1 SPECT imaging findings and clinical staging of Parkinson's disease: Does a correlation exist?

V Gupta, R Verma, R Ranjan, E Belho, H Mahajan - 2019 - Soc Nuclear Med
425 Objectives: To assess the pattern of 99m Tc-TRODAT-1 binding and to establish
correlation between decline in 99m Tc-TRODAT-1 uptake with increasing disease severity of …

Correlation of 99mTc-TRODAT-1 SPECT imaging findings and clinical staging of Parkinson disease

V Gupta, R Ranjan, R Verma, ES Belho… - Clinical Nuclear …, 2019 - journals.lww.com
Purpose The aims of this study were to evaluate 99m Tc-TRODAT-1 SPECT imaging
patterns and to assess their correlation with disease severity in clinically diagnosed patients …

Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects

YH Weng, TC Yen, MC Chen, PF Kao… - Journal of Nuclear …, 2004 - Soc Nuclear Med
The imaging of dopamine transporter (DAT) with 99mTc-TRODAT-1 ([2-[[2-[[[3-(4-
chlorophenyl)-8-methyl-8-azabicyclo [3, 2, 1] oct-2-yl] methyl](2-mercaptoethyl) amino] ethyl] …

Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson's disease versus other progressive movement disorders

B Fallahi, A Esmaeili, D Beiki, S Oveisgharan… - Annals of nuclear …, 2016 - Springer
Objective Parkinson disease (PD), parkinsonian syndromes (PS) and essential tremor (ET)
are different types of movement disorders which share some symptoms resulting in a …

Evaluation of 99Tcm-trodat-1 SPECT/CT imaging in the diagnosis of parkinson's disease in early stage

X Liu, J Tai, F Zhang, Q Xiao, Q Jia, F Dong - inis.iaea.org
[en] Parkinson's disease is a progressive neurodegenerative disorder characterized by a
selective loss of dopamine in the striatum with age. At present, the diagnosis of Parkinson's …

Complementary role of 99m-Tc-TRODAT-1 and FDG PET-CT in evaluating patients of Parkinson's disease and other movement disorders: 7 years experience from a …

R Verma, R Ranjan, C Agrawal… - Journal of the Neurological …, 2019 - jns-journal.com
Aims and objectives To gain firsthand experience in documenting the complementary role of
99mTc-TRODAT-1 and FDG PET CT imaging in the diagnosis and differentiation of various …

Evaluation of {sup 99} Tc {sup m}-trodat-1 SPECT/CT imaging in the diagnosis of parkinson's disease in early stage

L Xiaohua, T Jian, Z Fuhai, X Qian, J Qiang, D Feng - 2004 - osti.gov
Parkinson's disease is a progressive neurodegenerative disorder characterized by a
selective loss of dopamine in the striatum with age. At present, the diagnosis of Parkinson's …

Diagnostic evaluation of 99mTc-TRODAT-1 SPECT in parkinsonism

AZ Babaei, TS Najmi, A Arasteh, M Khalafi… - 2021 - sid.ir
Introduction: Parkinsonism as a group of movement disorders, exhibits similar clinical
presentation. Therefore, clinically differentiating these diseases is difficult. We investigated …

Diagnostic evaluation of 99mTc-TRODAT-1 SPECT in parkinsonism

ZB Aghdam, SN Tabrizi, A Arasteh… - Journal of Research …, 2021 - jrcm.tbzmed.ac.ir
Background Parkinsonism as a group of movement disorders, exhibit similar clinical
presentation. Therefore, clinically differentiating these diseases is difficult. We investigated …

Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging

WS Huang, SZ Lin, JC Lin, SP Wey… - Journal of Nuclear …, 2001 - Soc Nuclear Med
Parkinson's disease is a progressive neurodegenerative disorder characterized by a
selective loss of dopamine in the striatum. Problems remain in the accurate diagnosis of …